Bridging the gap: Global collaboration for group A streptococcus vaccines
Group A Streptococcus (Strep A) is a major global health concern, responsible for a wide range of diseases – from mild infections to severe invasive diseases like rheumatic heart disease and acute rheumatic fever, which cause serious health complications and death and disproportionately affect low- and middle-income countries. Despite this burden, the development of a Strep A vaccine is lagging and faces scientific and regulatory hurdles.
Advancing critical dialogue and collaboration on Strep A vaccine development, the International Vaccine Institute (IVI), in partnership with the Government of Sweden, Government of the Republic of Korea, and Government of Malawi, invite you to a breakfast meeting on the sidelines of the 78th World Health Assembly.
This in-person side event will bring together health officials, policymakers, researchers, and global health stakeholders to discuss actionable steps to:
- Understand the global burden of Strep A, including the use of surveillance and diagnostics.
- Share country experiences addressing Strep A.
- Mobilize global investment and coordinated action for Strep A vaccine development, including the Strep A Vaccine Global Consortium (SAVAC 2.0) initiative.
- Strengthen international partnerships.
Join us to contribute to shaping the global roadmap for Strep A prevention and vaccine development.